| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.273.49.32373 |
| P698 | PubMed publication ID | 9829963 |
| P50 | author | Tip W. Loo | Q43098486 |
| P2093 | author name string | D M Clarke | |
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| quality control | Q827792 | ||
| P304 | page(s) | 32373-32376 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Quality control by proteases in the endoplasmic reticulum. Removal of a protease-sensitive site enhances expression of human P-glycoprotein | |
| P478 | volume | 273 |
| Q28296585 | A novel stress-induced EDEM variant regulating endoplasmic reticulum-associated glycoprotein degradation |
| Q36564557 | Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. |
| Q44263795 | Benzo(c)quinolizinium drugs inhibit degradation of Delta F508-CFTR cytoplasmic domain. |
| Q33797023 | Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins |
| Q40090254 | Dark rearing rescues P23H rhodopsin-induced retinal degeneration in a transgenic Xenopus laevis model of retinitis pigmentosa: a chromophore-dependent mechanism characterized by production of N-terminally truncated mutant rhodopsin. |
| Q43560244 | Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil |
| Q41921953 | Degradation of human thyroperoxidase in the endoplasmic reticulum involves two different pathways depending on the folding state of the protein |
| Q51767890 | Demonstration that endoplasmic reticulum-associated degradation of glycoproteins can occur downstream of processing by endomannosidase. |
| Q40608295 | Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane |
| Q34710282 | Endoplasmic reticulum quality control of oligomeric membrane proteins: topogenic determinants involved in the degradation of the unassembled Na,K-ATPase alpha subunit and in its stabilization by beta subunit assembly |
| Q38308211 | Glycoprotein degradation: do sugars hold the key? |
| Q57976933 | Identification of Residues in the Drug-binding Domain of Human P-glycoprotein |
| Q57976930 | Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane |
| Q36427010 | In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin |
| Q38402177 | Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism |
| Q40240774 | Insertion of an arginine residue into the transmembrane segments corrects protein misfolding |
| Q39594613 | Making the cut: intramembrane cleavage by a rhomboid protease promotes ERAD. |
| Q44572793 | Multiple endoplasmic reticulum-associated pathways degrade mutant yeast carboxypeptidase Y in mammalian cells |
| Q40891908 | Mutations in the reduced-folate carrier affect protein localization and stability |
| Q55716450 | Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer's Disease Mouse Model. |
| Q40776579 | Release of polymannose oligosaccharides from vesicular stomatitis virus G protein during endoplasmic reticulum-associated degradation |
| Q36476116 | Rescue of folding defects in ABC transporters using pharmacological chaperones |
| Q44543802 | Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein |
| Q28575098 | Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate |
| Q35049666 | Stearoyl-CoA desaturase, a short-lived protein of endoplasmic reticulum with multiple control mechanisms |
| Q40082401 | Suppressor mutations in the transmembrane segments of P-glycoprotein promote maturation of processing mutants and disrupt a subset of drug-binding sites. |
| Q89802235 | The PAR2 signal peptide prevents premature receptor cleavage and activation |
| Q24791598 | The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator |
| Q27015793 | The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology |
| Q40313463 | Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket |
| Q39427313 | Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells |
Search more.